These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28152258)

  • 1. Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer.
    Waseda Y; Yoshida S; Takahara T; Kwee TC; Matsuoka Y; Saito K; Kihara K; Fujii Y
    J Magn Reson Imaging; 2017 Aug; 46(2):490-496. PubMed ID: 28152258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative evaluation of computed high B value diffusion-weighted magnetic resonance imaging of the prostate.
    Maas MC; Fütterer JJ; Scheenen TW
    Invest Radiol; 2013 Nov; 48(11):779-86. PubMed ID: 23907102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy.
    Verma S; Rajesh A; Morales H; Lemen L; Bills G; Delworth M; Gaitonde K; Ying J; Samartunga R; Lamba M
    AJR Am J Roentgenol; 2011 Feb; 196(2):374-81. PubMed ID: 21257890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Stratification of Prostate Cancer Using the Combination of Histogram Analysis of Apparent Diffusion Coefficient Across Tumor Diffusion Volume and Clinical Information: A Pilot Study.
    Zhang Z; Xu H; Xue Y; Li J; Ye Q
    J Magn Reson Imaging; 2019 Feb; 49(2):556-564. PubMed ID: 30173421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Exponential ADC (eADC) and Computed DWI (cDWI) for the Detection of Prostate Cancer.
    Sprinkart AM; Marx C; Träber F; Block W; Thomas D; Schild H; Kukuk GM; Mürtz P
    Rofo; 2018 Aug; 190(8):758-766. PubMed ID: 30045400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantified analysis of histological components and architectural patterns of gleason grades in apparent diffusion coefficient restricted areas upon diffusion weighted MRI for peripheral or transition zone cancer locations.
    Helfrich O; Puech P; Betrouni N; Pinçon C; Ouzzane A; Rizk J; Marcq G; Randazzo M; Durand M; Lakroum S; Leroy X; Villers A
    J Magn Reson Imaging; 2017 Dec; 46(6):1786-1796. PubMed ID: 28383776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histogram analysis of stretched-exponential and monoexponential diffusion-weighted imaging models for distinguishing low and intermediate/high gleason scores in prostate carcinoma.
    Liu W; Liu XH; Tang W; Gao HB; Zhou BN; Zhou LP
    J Magn Reson Imaging; 2018 Aug; 48(2):491-498. PubMed ID: 29412492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T2* relaxation time in the detection and assessment of aggressiveness of peripheral zone cancer in comparison with diffusion-weighted imaging.
    Wu LM; Zhou B; Lu Q; Suo ST; Liu Q; Hu J; Haccke EM; Chen XX; Xu JR
    Clin Radiol; 2016 Apr; 71(4):356-62. PubMed ID: 26823021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative Evaluation of Prostate Cancer Aggressiveness: Using ADC and ADC Ratio in Determining Gleason Score.
    Woo S; Kim SY; Cho JY; Kim SH
    AJR Am J Roentgenol; 2016 Jul; 207(1):114-20. PubMed ID: 27077643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
    Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
    Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma.
    Lim C; Flood TA; Hakim SW; Shabana WM; Quon JS; El-Khodary M; Thornhill RE; El Hallani S; Schieda N
    J Magn Reson Imaging; 2016 Mar; 43(3):726-36. PubMed ID: 26303719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours.
    Bittencourt LK; Barentsz JO; de Miranda LC; Gasparetto EL
    Eur Radiol; 2012 Feb; 22(2):468-75. PubMed ID: 21913058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental value of high b value diffusion-weighted magnetic resonance imaging at 3-T for prediction of extracapsular extension in patients with prostate cancer: preliminary experience.
    Kido A; Tamada T; Sone T; Kanomata N; Miyaji Y; Yamamoto A; Ito K
    Radiol Med; 2017 Mar; 122(3):228-238. PubMed ID: 27943099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of diffusion-weighted MRI for prostate cancer detection and localization.
    Yağci AB; Ozari N; Aybek Z; Düzcan E
    Diagn Interv Radiol; 2011 Jun; 17(2):130-4. PubMed ID: 20694948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between apparent diffusion coefficient value on diffusion-weighted MR imaging and Gleason score in prostate cancer.
    Wu X; Reinikainen P; Vanhanen A; Kapanen M; Vierikko T; Ryymin P; Hyödynmaa S; Kellokumpu-Lehtinen PL
    Diagn Interv Imaging; 2017 Jan; 98(1):63-71. PubMed ID: 27687831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and Diagnostic Performance of Voxelwise Computed Diffusion-Weighted Imaging in Breast Cancer.
    Zhou J; Chen E; Xu H; Ye Q; Li J; Ye S; Cheng Q; Zhao L; Su MY; Wang M
    J Magn Reson Imaging; 2019 Jun; 49(6):1610-1616. PubMed ID: 30328211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.
    Nowak J; Malzahn U; Baur AD; Reichelt U; Franiel T; Hamm B; Durmus T
    Acta Radiol; 2016 Jan; 57(1):107-14. PubMed ID: 25505225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of fitting models for prostate tissue characterization using extended-range b-factor diffusion-weighted imaging.
    Langkilde F; Kobus T; Fedorov A; Dunne R; Tempany C; Mulkern RV; Maier SE
    Magn Reson Med; 2018 Apr; 79(4):2346-2358. PubMed ID: 28718517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of PI-RADS 2, ADC histogram-derived parameters, and their combination for the diagnosis of peripheral zone prostate cancer.
    Lin WC; Westphalen AC; Silva GE; Chodraui Filho S; Reis RB; Muglia VF
    Abdom Radiol (NY); 2016 Nov; 41(11):2209-2217. PubMed ID: 27364781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.